Healthdirect Australia is not responsible for the content and advertising on the external website you are now entering.
Brand name: Act-Hib TM
Active ingredients: haemophilus influenzae type b conjugate (prp-tt) vaccine
What it is used for
For use in infants from 2 months to 5 years of age for active immunization against invasive disease caused by the Haemophilus influenzae type b.
How to take it
This medicine is a pack that contains more than one part.
Part 1: Injection, powder for
Lyophilised vaccine: type 1 glass vial sealed with elastomer stopper and aluminium/plastic seal.
The way to take this medicine is: Intramuscular. This medicine is given through a needle inserted into the muscle beneath the skin.
Part 2: Diluent, not applicable
Diluent: clear colourless solution.
The way to take this medicine is: Intramuscular. This medicine is given through a needle inserted into the muscle beneath the skin.
You should seek medical advice in relation to medicines and use only as directed by a healthcare professional.
Always read the label. If symptoms persist see your healthcare professional.
Storage instructions
- Store at 2 to 8 degrees Celsius
- Shelf lifetime is 3 Years.
Do I need a prescription?
This medicine is available from a pharmacist and requires a prescription. It is
Pregnant or planning a pregnancy?
For the active ingredient haemophilus influenzae type b conjugate (prp-tt) vaccine
You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.
Consumer Medicines Information (CMI)
For side effects, taking other medicines and more
Reporting side effects
You can help ensure medicines are safe by reporting the side effects you experience.
You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems
Need more information?
These trusted information partners have more on this topic.
Top results
List of nationally notifiable diseases | Australian Government Department of Health and Aged Care
This page lists diseases that states and territories have agreed to report to us through the National Notifiable Diseases Surveillance System.
Read more on Australian Government Department of Health and Aged Care website
Japanese encephalitis | NCIRS
Japanese encephalitis NCIRS fact sheets, FAQs and other resources Australian Immunisation Handbook COVID-19 vaccines Immunisation coverage data and reports Education and training History of immunisation Immunisation schedules National and international resources NCIRS fact sheets, FAQs and other resources COVID-19 COVID-19 vaccination from community pharmacy Vaccination from community pharmacy Supporting conversations about vaccinations with Aboriginal and Torres Strait Islander people Haemophilus influenzae type b (Hib) Hepatitis B Human papillomavirus Influenza Japanese encephalitis Measles Meningococcal Mpox (formerly known as monkeypox) Mumps Pertussis Pneumococcal Poliomyelitis Rotavirus Rubella Varicella-zoster (chickenpox) Zoster Vaccines for Australian adults Vaccinations during pregnancy Homeopathy and vaccination MMR vaccine, inflammatory bowel disease and autism Thiomersal Vaccines, allergy and asthma Vaccine components Measles vaccination catch-up guide Injection site reactions Enhancing data quality of vaccination encounter records: tips and tricks Supporting and understanding delegations in HPOS to enable access to the Australian Immunisation Register NCIRS webinar series Patient communication resources Specialist immunisation services SKAI - supporting health professionals NCIRS newsletters Vaccine safety The Japanese encephalitis (JE) situation in Australia has been declared a Communicable Disease Incident of National Significance as of March 2022
Read more on National Centre for Immunisation Research and Surveillance (NCIRS) website
Top results